Rapid Cognitive Improvement in Alzheimer's Disease with Etanercept
Author Information
Author(s): Edward L Tobinick, Hyman Gross
Primary Institution: Department of Medicine, Institute for Neurological Research, Los Angeles, USA
Hypothesis
The administration of perispinal etanercept will lead to rapid cognitive improvement in patients with Alzheimer's disease.
Conclusion
The study found that perispinal etanercept administration resulted in rapid cognitive improvement in a patient with late-onset Alzheimer's disease.
Supporting Evidence
- Etanercept is known to block the effects of excess TNF-alpha, which is implicated in Alzheimer's disease.
- The patient showed marked cognitive improvement within minutes of treatment.
- Family members confirmed the patient's cognitive improvements after treatment.
Takeaway
A patient with Alzheimer's disease got much better at thinking and remembering just minutes after getting a special treatment called etanercept.
Methodology
The patient received a single dose of 25 mg of etanercept via perispinal administration, followed by cognitive assessments before and after treatment.
Potential Biases
All participants, including the examining physicians, were aware of the treatment modality, which could bias the results.
Limitations
The study is based on a single case report, and the authors acknowledge potential bias due to the lack of a control group.
Participant Demographics
The patient was an 81-year-old male physician with late-onset Alzheimer's disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website